Class II · Moderate risk Ongoing
Naproxen Oral Suspension
Reason Chemical contamination; presence of lead and lithium above specification
Doxazosin Tablets
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Cross Contamination w/Other Products: During stability testing chromatographic review revealed extraneous peaks identified as acetaminophen and codeine.
What was recalled
Doxazosin Tablets, USP, 2 mg, 100 count bottles, labeled in part ***Manufactured in Australia by: ALPHAPHARM PTY LTD, 15 Garnet Street***Rx Only*** Carole Park QLD 4300, Australia*** Manufactured for Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.SA ***
- Recalling firm
- Mylan Pharmaceuticals Inc.
- Origin
- WV, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-033-2013
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Alpha recalls
See all
Class II · Moderate risk Ongoing
Doxycycline Hyclate Tablets
Reason Failed dissolution specifications: Stability testing found that the lot did not meet dissolution specifications.
Class II · Moderate risk Ongoing
Alpha Lipoic Acid for Injection
Reason Lack of Assurance of Sterility
Class II · Moderate risk Terminated
Methylphenidate Hydrochloride
Reason Failed dissolution specifications: this product is being recalled due to this batch not meeting dissolution specifications.
Class III · Low risk Terminated
Sodium Sulfacetamide 10% - Sulfur 5% Cleanser
Reason Subpotent drug
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.